Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 33,390 | -10,640 | -4,140 | -2,580 | 10,570 |
| Depreciation Amortization | 9,420 | 8,600 | 6,080 | 2,380 | 7,600 |
| Other Working Capital | 250 | 3,930 | 2,260 | -6,510 | 1,280 |
| Other Operating Activity | -35,110 | 12,450 | 4,290 | 3,410 | -6,520 |
| Operating Cash Flow | $7,950 | $14,340 | $8,490 | $-3,300 | $12,930 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,890 | -2,520 | -1,510 | -570 | -1,740 |
| Net Acquisitions | 11,890 | -10,830 | -8,000 | -1,120 | -92,640 |
| Other Investing Activity | -28,650 | 7,850 | 7,360 | 3,730 | -1,160 |
| Investing Cash Flow | $-18,650 | $-5,500 | $-2,150 | $2,040 | $-95,540 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -8,570 | -9,840 | -7,040 | -1,240 | 88,920 |
| Financing Cash Flow | $-8,570 | $-9,840 | $-7,040 | $-1,240 | $88,920 |
| Exchange Rate Effect | 1,350 | 1,350 | 1,320 | 310 | -2,780 |
| Beginning Cash Position | 27,260 | 27,260 | 27,260 | 27,260 | 23,730 |
| End Cash Position | 9,350 | 27,620 | 27,890 | 25,080 | 27,260 |
| Net Cash Flow | $-17,910 | $350 | $620 | $-2,180 | $3,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,950 | 14,340 | 8,490 | -3,300 | 12,930 |
| Free Cash Flow | 7,950 | 14,340 | 8,490 | -3,300 | 12,930 |